Financial Ratios

ALLIED HERBALS LTD.

NSE : NABSE : 523030ISIN CODE : INE608D01016Industry : Finance - NBFCHouse : Private
BSE24.450 (0 %)
PREV CLOSE ( ) 24.45
OPEN PRICE ( ) 24.45
BID PRICE (QTY) 0.00 (0)
OFFER PRICE (QTY) 0.00 (0)
VOLUME 1
TODAY'S LOW / HIGH ( )24.45 24.45
52 WK LOW / HIGH ( ) 24.4524.45
NSE
This Company is not listed in NSE
Select year
ParticularsMar2016Mar2015Mar2014Mar2013Mar2012
Operational & Financial Ratios
   Earnings Per Share (Rs)-0.36-0.23-0.12-0.32-0.60
   CEPS(Rs)-0.36-0.23-0.12-0.32-0.60
   DPS(Rs)0.000.000.000.000.00
   Book NAV/Share(Rs)9.619.9710.1910.3210.63
   Tax Rate(%)0.000.000.000.000.00
Margin Ratios
   Core EBITDA Margin(%)
   EBIT Margin(%)
   Pre Tax Margin(%)
   PAT Margin (%)
   Cash Profit Margin (%)
Performance Ratios
   ROA(%)-3.15-1.98-1.07-2.75-5.19
   ROE(%)-3.68-2.26-1.21-3.02-5.48
   ROCE(%)-3.22-2.02-1.07-2.78-5.28
   Asset Turnover(x)0.000.000.000.000.00
   Sales/Fixed Asset(x)
   Working Capital/Sales(x)0.000.000.000.000.00
Efficiency Ratios
   Fixed Capital/Sales(x)
   Receivable days
   Inventory Days
   Payable days
Valuation Parameters
   PER(x)0.000.000.000.000.00
   PCE(x)0.00-163.06-306.50-142.02-87.95
   Price/Book(x)0.003.723.734.364.96
   Yield(%)0.000.000.000.00
   EV/Net Sales(x)
   EV/Core EBITDA(x)-31.68-168.27-318.31-145.07-88.90
   EV/EBIT(x)-31.68-168.27-318.31-145.07-88.90
   EV/CE(x)1.003.333.393.894.70
   M Cap / Sales
Growth Ratio
   Net Sales Growth(%)
   Core EBITDA Growth(%)-57.60-85.7061.2747.20-2608.55
   EBIT Growth(%)-57.60-85.7061.2747.20-2608.55
   PAT Growth(%)-58.09-83.5160.8747.12-2438.61
   EPS Growth(%)-58.11-83.4960.8847.11-2438.64
Financial Stability Ratios
   Total Debt/Equity(x)0.140.130.110.120.05
   Current Ratio(x)0.221.111.835.870.01
   Quick Ratio(x)0.221.111.835.870.02
   Interest Cover(x)-204.96-577.02-73.24-309.93-588.06
   Total Debt/Mcap(x)0.030.030.030.01

© NIRMAL BANG. All rights reserved

Designed , Developed & Content Powered by Accord Fintech Pvt. Ltd.

Open an Account
FOR AFREE *DEMAT & BROKING ACCOUNT

Please fill in the details below

Close X

(Note - You will receive a call from our sales executive)

CLOSE X

RISK DISCLOSURES ON DERIVATIVES

  • 9 out of 10 individual traders in equity Futures and Options Segment, incurred net losses.
  • On an average, loss makers registered net trading loss close to ₹ 50,000.
  • Over and above the net trading losses incurred, loss makers expended an additional 28% of net trading losses as transaction costs.
  • Those making net trading profits, incurred between 15% to 50% of such profits as transaction cost.

Source:

1. SEBI study dated January 25, 2023 on “Analysis of Profit and Loss of Individual Traders dealing in equity Futures and Options (F&O) Segment”, wherein Aggregate Level findings are based on annual Profit/Loss incurred by individual traders in equity F&O during FY 2021-22.